| St John's Wort Decreases the Bioavailability of R‐ and S‐verapamil Through Induction of the First‐pass Metabolism C Tannergren, H Engman, L Knutson, M Hedeland, U Bondesson, ... Clinical Pharmacology & Therapeutics 75 (4), 298-309, 2004 | 178 | 2004 |
| Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex E Jerremalm, M Hedeland, I Wallin, U Bondesson, H Ehrsson Pharmaceutical research 21, 891-894, 2004 | 95 | 2004 |
| Multiple transport mechanisms involved in the intestinal absorption and first‐pass extraction of fexofenadine C Tannergren, N Petri, L Knutson, M Hedeland, U Bondesson, ... Clinical Pharmacology & Therapeutics 74 (5), 423-436, 2003 | 88 | 2003 |
| Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing S Guddat, G Fußhöller, S Beuck, A Thomas, H Geyer, A Rydevik, ... Analytical and bioanalytical chemistry 405, 8285-8294, 2013 | 74 | 2013 |
| Management of animal botulism outbreaks: from clinical suspicion to practical countermeasures to prevent or minimize outbreaks F Anniballi, A Fiore, C Löfström, H Skarin, B Auricchio, C Woudstra, ... Biosecurity and bioterrorism: biodefense strategy, practice, and science 11 …, 2013 | 71 | 2013 |
| Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase E Bergman, P Forsell, A Tevell, EM Persson, M Hedeland, U Bondesson, ... European journal of pharmaceutical sciences 29 (3-4), 205-214, 2006 | 65 | 2006 |
| Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass … A Tevell, H Lennernäs, M Jönsson, M Norlin, B Lennernäs, U Bondesson, ... Drug metabolism and disposition 34 (6), 984-992, 2006 | 62 | 2006 |
| Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing L Tretzel, A Thomas, T Piper, M Hedeland, H Geyer, W Schänzer, ... Journal of pharmaceutical and biomedical analysis 123, 132-140, 2016 | 60 | 2016 |
| The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men A Lundahl, M Hedeland, U Bondesson, L Knutson, H Lennernäs European journal of pharmaceutical sciences 36 (4-5), 433-443, 2009 | 54 | 2009 |
| Non-aqueous capillary electrophoretic separation of enantiomeric amines with (−)-2, 3: 4, 6-di-O-isopropylidene-2-keto-l-gulonic acid as chiral counter ion Y Carlsson, M Hedeland, U Bondesson, C Pettersson Journal of Chromatography A 922 (1-2), 303-311, 2001 | 54 | 2001 |
| Development of a chiral non-aqueous capillary electrophoretic system using the partial filling technique with UV and mass spectrometric detection H Lodén, Y Hedeland, M Hedeland, U Bondesson, C Pettersson Journal of Chromatography A 986 (1), 143-152, 2003 | 53 | 2003 |
| First-pass effects of verapamil on the intestinal absorption and liver disposition of fexofenadine in the porcine model N Petri, E Bergman, P Forsell, M Hedeland, U Bondesson, L Knutson, ... Drug metabolism and disposition 34 (7), 1182-1189, 2006 | 51 | 2006 |
| Seafood sold in Sweden contains BMAA: A study of free and total concentrations with UHPLC–MS/MS and dansyl chloride derivatization ML Salomonsson, E Fredriksson, A Alfjorden, M Hedeland, U Bondesson Toxicology reports 2, 1473-1481, 2015 | 45 | 2015 |
| Identification of glucuronide conjugates of ketobemidone and its phase I metabolites in human urine utilizing accurate mass and tandem time‐of‐flight mass spectrometry I Sundström, M Hedeland, U Bondesson, PE Andrén Journal of mass spectrometry 37 (4), 414-420, 2002 | 45 | 2002 |
| Cellobiohydrolase I as a chiral additive in capillary electrophoresis and liquid chromatography M Hedeland, R Isaksson, C Pettersson Journal of Chromatography A 807 (2), 297-305, 1998 | 45 | 1998 |
| Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes A Hansson, H Knych, S Stanley, M Thevis, U Bondesson, M Hedeland Drug testing and analysis 7 (8), 673-683, 2015 | 44 | 2015 |
| Detection of altrenogest and its metabolites in post administration horse urine using liquid chromatography tandem mass spectrometry—increased sensitivity by chemical … M Lampinen-Salomonsson, E Beckman, U Bondesson, M Hedeland Journal of Chromatography B 833 (2), 245-256, 2006 | 44 | 2006 |
| The differences in matrix effect between supercritical fluid chromatography and reversed phase liquid chromatography coupled to ESI/MS A Svan, M Hedeland, T Arvidsson, CE Pettersson Analytica chimica acta 1000, 163-171, 2018 | 43 | 2018 |
| Characterization of a non‐approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase‐I … M Thevis, A Lagojda, D Kuehne, A Thomas, J Dib, A Hansson, ... Rapid Communications in Mass Spectrometry 29 (11), 991-999, 2015 | 43 | 2015 |
| Enterohepatic disposition of rosuvastatin in pigs and the impact of concomitant dosing with cyclosporine and gemfibrozil E Bergman, A Lundahl, P Fridblom, M Hedeland, U Bondesson, ... Drug metabolism and disposition 37 (12), 2349-2358, 2009 | 39 | 2009 |
Erik SjögrenPhD BiopharmaceuticsVerified email at farmaci.uu.se
